Showing results (61-70 of 316) with videos related to

Sort By:
Pageof 32
Nature Reviews. Nephrology|February 18, 2015
HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatmentAvi Z Rosenberg, Saraladevi Naicker, Cheryl A Winkler, et al.
Kidney International|April 1, 2021
APOL1 at 10 years: progress and next stepsBarry I Freedman, Jeffrey B Kopp, Matthew G Sampson, et al.
Nature Reviews. Nephrology|February 26, 2022
The evolving story of apolipoprotein L1 nephropathy: the end of the beginningParnaz Daneshpajouhnejad, Jeffrey B Kopp, Cheryl A Winkler, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Deciphering Environmental Health Factors Behind Unknown Etiology of Chronic Kidney Disease in South Asia: Plans for Epidemiologic StudyAnirudh Mazumder, Sebastian Pintea, Aneesh Mazumder, et al.
NDT Plus|May 8, 2015
Adenovirus nephritis and obstructive uropathy in a renal transplant recipient: case report and literature reviewLuiz M Kolankiewicz, James Pullman, Mark Raffeld, et al.
American Journal of Physiology. Renal Physiology|February 28, 2014
Human podocytes perform polarized, caveolae-dependent albumin endocytosisEvgenia Dobrinskikh, Kayo Okamura, Jeffrey B Kopp, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 17, 2006
NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE reviewNora Franceschini, Kari E North, Jeffrey B Kopp, et al.
BMC Nephrology|July 15, 2020
Macrophage polarization in innate immune responses contributing to pathogenesis of chronic kidney diseaseHewang Lee, Michael B Fessler, Peng Qu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2017
Therapeutics for APOL1 nephropathies: putting out the fire in the podocyteJurgen Heymann, Cheryl A Winkler, Maarten Hoek, et al.
American Journal of Physiology. Renal Physiology|May 12, 2007
In vitro models of TGF-beta-induced fibrosis suitable for high-throughput screening of antifibrotic agentsQihe Xu, Jill T Norman, Shashi Shrivastav, et al.
Pageof 32